Atlas-Venture-Life-Science-Advisors

AI_NATIVE detailed information: This accession holds the following tickers:[
  "THRD",
  "KYMR",
  "KRRO",
  "QTTB",
  "SPRO",
  null,
  "DYN",
  null,
  "GBIO",
  "IKNA",
  "VIGL",
  "DAWN",
  "IRON"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-14
Total Holdings: 13
Total Value: 521764233
Accession Number: 0001104659-25-048527
Form Type: 13F-HR
CIK: atlas-venture-life-science-advisors
Manager Name: Atlas-Venture-Life-Science-Advisors

Data Enrichment

85% identified

11 identified2 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

13 positions • $521.8M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

Kymera Therapeutics, Inc.

KYMR|501575104

Shares:4.9M

Value:$134.0M

% of Portfolio:25.7% ($134.0M/$521.8M)

Disc Medicine, Inc.

IRON|254604101

Shares:2.4M

Value:$118.4M

% of Portfolio:22.7% ($118.4M/$521.8M)

Dyne Therapeutics, Inc.

DYN|26818M108

Shares:9.1M

Value:$95.5M

% of Portfolio:18.3% ($95.5M/$521.8M)

Day One Biopharmaceuticals, Inc.

DAWN|23954D109

Shares:6.4M

Value:$51.0M

% of Portfolio:9.8% ($51.0M/$521.8M)

829401108

Shares:3.7M

Value:$38.6M

% of Portfolio:7.4% ($38.6M/$521.8M)

Third Harmonic Bio, Inc.

THRD|88427A107

Shares:10.4M

Value:$36.1M

% of Portfolio:6.9% ($36.1M/$521.8M)

Korro Bio, Inc.

KRRO|500946108

Shares:1.1M

Value:$19.8M

% of Portfolio:3.8% ($19.8M/$521.8M)

Vigil Neuroscience, Inc.

VIGL|92673K108

Shares:5.8M

Value:$10.4M

% of Portfolio:2.0% ($10.4M/$521.8M)

Ikena Oncology, Inc.

IKNA|45175G108

Shares:5.0M

Value:$6.4M

% of Portfolio:1.2% ($6.4M/$521.8M)

008064107

Shares:1.8M

Value:$4.5M

% of Portfolio:0.9% ($4.5M/$521.8M)

Q32 Bio Inc.

QTTB|746964105

Shares:2.1M

Value:$3.5M

% of Portfolio:0.7% ($3.5M/$521.8M)

Generation Bio Co.

GBIO|37148K100

Shares:8.3M

Value:$3.4M

% of Portfolio:0.6% ($3.4M/$521.8M)

Spero Therapeutics, Inc.

SPRO|84833T103

Shares:305.3K

Value:$219.8K

% of Portfolio:0.0% ($219.8K/$521.8M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Kymera Therapeutics, Inc.(KYMRcusip501575104)	4.9M	QoQ 0.00% (-0) YoY -8.94% (-480.9K)	All Managers (Combined)	$134.0M	25.7% ($134.0M/$521.8M)	QoQ -31.96% (-$63.0M) YoY -38.00% (-$82.2M)
Disc Medicine, Inc.(IRONcusip254604101)	2.4M	QoQ -4.98% (-125.0K) YoY +4.25% (-97.2K)	All Managers (Combined)	$118.4M	22.7% ($118.4M/$521.8M)	QoQ -25.60% (-$40.7M) YoY -16.88% (-$24.0M)
Dyne Therapeutics, Inc.(DYNcusip26818M108)	9.1M	QoQ +13.85% (-1.1M) YoY +13.84% (-1.1M)	All Managers (Combined)	$95.5M	18.3% ($95.5M/$521.8M)	QoQ -49.45% (-$93.4M) YoY -58.05% (-$132.2M)
Day One Biopharmaceuticals, Inc.(DAWNcusip23954D109)	6.4M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$51.0M	9.8% ($51.0M/$521.8M)	QoQ -37.41% (-$30.5M) YoY -51.99% (-$55.2M)
(cusip829401108)✕	3.7M	QoQ NEW(+3.7M) YoY NEW(+3.7M)	All Managers (Combined)	$38.6M	7.4% ($38.6M/$521.8M)	QoQ NEW(+$38.6M) YoY NEW(+$38.6M)
Third Harmonic Bio, Inc.(THRDcusip88427A107)	10.4M	QoQ 0.00% (-0) YoY -4.63% (-505.6K)	All Managers (Combined)	$36.1M	6.9% ($36.1M/$521.8M)	QoQ -66.27% (-$70.9M) YoY -64.94% (-$66.9M)
Korro Bio, Inc.(KRROcusip500946108)	1.1M	QoQ 0.00% (-0) YoY +1.59% (-17.9K)	All Managers (Combined)	$19.8M	3.8% ($19.8M/$521.8M)	QoQ -54.26% (-$23.5M) YoY -80.34% (-$80.9M)
Vigil Neuroscience, Inc.(VIGLcusip92673K108)	5.8M	QoQ 0.00% (+0) YoY 0.00% (-0)	All Managers (Combined)	$10.4M	2.0% ($10.4M/$521.8M)	QoQ +4.70% (+$466.9K) YoY -47.80% (-$9.5M)
Ikena Oncology, Inc.(IKNAcusip45175G108)	5.0M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$6.4M	1.2% ($6.4M/$521.8M)	QoQ -21.95% (-$1.8M) YoY -9.85% (-$702.5K)
(cusip008064107)✕	1.8M	QoQ 0.00% (-0) YoY -11.76% (-240.0K)	All Managers (Combined)	$4.5M	0.9% ($4.5M/$521.8M)	QoQ -5.28% (-$251.9K) YoY -92.51% (-$55.8M)
Q32 Bio Inc.(QTTBcusip746964105)	2.1M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$3.5M	0.7% ($3.5M/$521.8M)	QoQ -52.03% (-$3.7M) YoY -90.31% (-$32.2M)
Generation Bio Co.(GBIOcusip37148K100)	8.3M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$3.4M	0.6% ($3.4M/$521.8M)	QoQ -61.79% (-$5.4M) YoY -90.04% (-$30.3M)
Spero Therapeutics, Inc.(SPROcusip84833T103)	305.3K	QoQ 0.00% (-0) YoY -49.76% (-302.4K)	All Managers (Combined)	$219.8K	0.0% ($219.8K/$521.8M)	QoQ -30.09% (-$94.6K) YoY -78.96% (-$825.3K)